A $7 billion or 5.8 billion euro stock and cash deal is in the works for VNU and IMS Health, as the two companies announced today that they will be merging. The combined company will be listed on both the Euronext Amsterdam and the New York Stock Exchange. VNU shareholders will control about 65% of the company, while IMS shareholders control about 35%. "This merger of two industry leaders gives us the scale and capabilities to meet growing client demand for the must-have market intelligence that drives critical business decisions," said VNU CEO Rob van den Bergh, who will be CEO of the combined company.
latest ebusiness news. 
No comments yet. Be the first to comment!